NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

iTonic Holdings Ltd. (ITOC) Stock Analysis

iTonic Holdings Ltd. (ITOC) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

ITOC

$3.54

+$0.19 (+5.67%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ITOC with… →

ITOC Key Statistics

As of Oct 21, 2026
Trading
Open
$3.40
Previous Close
$3.35
Day's Range
3.39–3.54
52-Week Range
3.27–18.40
Volume
2.23K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.79
Valuation
Market Cap
$25.90M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
46.54
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.22
Financials (FY)
Revenue (FY)
$523.03K+16.70%
Net Income (FY)
−$5.10M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
6.84M
1-Year Return
−64.88%
Dividend and dates
Avg Volume
53.18K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ITOC closed at $3.54, −64.88% over 1 year.

iTonic Holdings Ltd. (ITOC) has a market capitalization of $25.90M.

In fiscal 2025, ITOC reported revenue of $523.03K.

ITOC Stock Return by Calendar Year

iTonic Holdings Ltd. (ITOC) return since Sep 2024: what $10,000 became

1 year
$10,000 $3,512
−64.88%
Since Sep 2024
$10,000 $585
−94.15%

If you had invested $10,000 in iTonic Holdings Ltd. (ITOC) at the close on September 5, 2024, the earliest close on record here, it would have been worth $585 at the close on October 21, 2026: −94.15% in total, −73.71% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−47.45%
2025−90.45%
2024 (partial year)+16.67%

As of October 21, 2026.

ITOC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$523.03K−$5.10M−974.7%
2024$448.20K−$660.59K−147.4%
2023$628.59K−$241.22K−38.4%
2022$679.78K$83.98K12.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$523.03K$327.35K−$5.16M−$5.10M−974.7%
2024$448.20K$381.16K−$661.96K−$660.59K−147.4%
2023$628.59K$470.83K−$258.51K−$241.22K−38.4%
2022$679.78K$558.15K$74.53K$83.98K12.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ITOC Valuation vs Medical Devices Median

Median of 145 stocks
MetricITOCMedical Devices medianvs median
P/S ratio46.542.5318.4x the median

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values iTonic Holdings Ltd. (ITOC) at $25.90M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 7 employees.

ITOC last closed at $3.54 on October 21, 2026. That is +$0.19 (+5.67%) against the previous close. The 52-week range on file runs from $3.27 to $18.40. The latest close sits 8.16% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $523.03K. Against the prior fiscal year total of $448.20K, that is a change of +16.70%. The same year closed with a net loss of $5.10M. Earnings per share on a trailing basis come to −4.22.

Across the 4 fiscal years on file, revenue moves from $679.78K in 2022 to $523.03K in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 46.54 times revenue. On price-to-sales that is 18.4 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −64.88%. The stored price history starts on September 5, 2024, and the total return since then is −94.15%. The reported beta is 2.79. Annualized volatility over the trailing 2 years is 166.47%.

Growth & Income

No dividend is on file for ITOC.

So far in 2026 the total return is −47.45%. The record holds one complete calendar year, 2025, which returned −90.45%.

Peer Comparison

iTonic Holdings Ltd. (ITOC) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
iTonic Holdings Ltd. ITOC $25.90M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. iTonic Holdings Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About iTonic Holdings Ltd.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Visit website →